Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-12-03FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Prochlorperazine edisylate from Civica, Inc. to update the labeling per the supplement. The appr…
-
FDA approval · 2010-11-30FDA Approved: ONDANSETRON — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Dr. Reddy's Laboratories Limited, allowing continued approval…
-
FDA approval · 2010-11-30FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ondansetron submitted by Hikma Pharmaceuticals USA, indicating a regulatory update to the pr…
-
FDA approval · 2010-11-18FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for REGLAN (metoclopramide hydrochloride) from ANI Pharmaceuticals, representing an approved regulat…
-
FDA approval · 2010-09-15FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
The FDA has approved a supplemental application for granisetron hydrochloride submitted by Bionpharma Inc., maintaining regulatory approval …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015) [Phase 3]
Phase 3 study evaluating safety and tolerability of MK0517 for the prevention of postoperative nausea and vomiting has completed. Results we…
-
FDA approval · 2010-06-03FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for metoclopramide from Teva Parenteral Medicines, Inc., updating the product's approval status as p…
-
CLINICAL_TRIALS research · 2010-05-27Clinical Trial Update: Physostigmine After General Anesthesia [NA]
This clinical trial update concerns the use of physostigmine after general anesthesia for postoperative nausea and vomiting and anesthesia r…
-
FDA approval · 2010-04-12FDA Approved: ONDANSETRON — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for generic ondansetron by Rising Pharma Holdings, Inc. for prevention of nausea and vomiting in posto…
-
FDA approval · 2010-04-09FDA Approved: GRANISETRON HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved Mylan Institutional LLC's Original Application for granisetron hydrochloride, a generic version of granisetron. The approval co…
-
FDA approval · 2010-04-09FDA Approved: GRANISETRON HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved granisetron hydrochloride under an original generic application (ANDA) for preventing nausea and vomiting caused by chemotherap…
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals’ supplemental application for metoclopramide, updating the regulatory status of this generic drug.
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for metoclopramide (generic).
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting [NA]
The clinical trial evaluating prophylactic dimenhydrinate for postoperative nausea and vomiting has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-26Clinical Trial Update: Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients [NA]
A completed trial evaluating the efficacy and safety of dexamethasone as an antiemetic in obstetric surgical patients with postoperative nau…
-
CLINICAL_TRIALS research · 2009-12-31Clinical Trial Update: The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy [NA]
Clinical trial update evaluating oral and IV Ramosetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cho…
-
FDA approval · 2009-12-23FDA Approved: GRANISETRON HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves an original application for granisetron hydrochloride (generic) by Hikma Pharmaceuticals USA Inc. as a generic antiemetic to pr…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Dexamethasone Improves Postoperative Symptoms After Laparoscopic Cholecystectomy [Phase 3]
Phase 3 trial shows dexamethasone reduces postoperative nausea and vomiting and postoperative pain after laparoscopic cholecystectomy.
-
FDA approval · 2009-12-01FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved Ipca Laboratories Limited's supplemental application for Metoclopramide, granting approval of a generic version of the drug. Th…
-
FDA approval · 2009-11-06FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's metoclopramide product, updating its regulatory status as a marketed generic drug.
-
CLINICAL_TRIALS research · 2009-11-02Clinical Trial Update: Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)
This document reports on the completed development of a predictive model to forecast post-discharge nausea and vomiting following surgery, l…
-
EMA withdrawal · 2009-10-13EMA Application withdrawn: Zunrisa (casopitant) — Glaxo Group Ltd
The EMA withdrew the application for Zunrisa (casopitant) from Glaxo Group Ltd for indications in vomiting, postoperative nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: Study of Nicotine for the Prevention of PONV [Phase 2]
A Phase 2 clinical trial evaluating nicotine for the prevention of postoperative nausea and vomiting was terminated.
-
FDA approval · 2009-09-25FDA Approved: ONDANSETRON — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for ondansetron from Heritage Pharmaceuticals (Avet) as a generic antiemetic to prevent nausea and vomiting du…
-
FDA approval · 2009-09-11FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for METOCLOPRAMIDE HYDROCHLORIDE submitted by Chartwell Governmental & Specialty RX, LLC.